Documents used include official guides from UK Department of Health,  UK National Institute for Clinical Eexcellence (NICE), charity Diabetes UK, and others, as set out below.

  1. Diabetes in adults, NICE quality standard [QS6] Published date: March 2011
  2. NICE Diabetes in pregnancy: management from preconception to the postnatal period (NG3) February 2015; 
  3. Diabetic foot problems: prevention and management, NICE NG19, August 2015; 
  4. Type 1 diabetes in adults: diagnosis and management, NICE NG17, August 2015; 
  5. Type 2 diabetes in adults: management, NICE NG28, December 2015; 
  6. Type 2 diabetes prevention: population and community-level interventions, and preventing the progression from 'pre-diabetes' to type 2 diabetes NICE Guidelines (PH35), May 2011; 
  7. Type 2 diabetes: prevention in people at high risk, NICE PH38, July 2012. 
  8. Knowler WC, Fowler SE, Hamman RF, et al.: 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009; 374(9702):1677-86.
  9. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med. 2002;346(6):393-403.
  10. The Healthier You: NHS (England) Diabetes Prevention Programme, March 2015
  11. USA Diabetes Prevention Program (DPP) and The Diabetes Prevention Program Outcomes Study (DPPOS), the 10-year follow-up study to the DPP. This research study proved that type 2 diabetes could be prevented or delayed in persons with increased risk by losing a small amount of weight and getting 30 minutes of moderate-intensity physical activity, such as brisk walking, five days a week. Diabetes Care 2012; 35(4):723-30.
  12. NICE CVDs risk assessment and management, September 2014; 
  13. Cardiovascular disease prevention NICE guidelines PH25, June 2010; 
  14. Quality standard for cardiovascular risk assessment and lipid modification NICE QS 100, and NICE guidelines CG181 July 2014;  
  15. Quality standard on secondary prevention following a myocardial infarction (heart attack)  NICE QS 99; 
  16. Lipid modification (2014) NICE guideline CG181.
  17. New NICE quality standard to reduce the risk of heart attacks and strokes, Sept. 2015;
  18. Diabetes patients requiring glucose-lowering therapy and non-diabetics with a prior myocardial infarction carry the same cardiovascular risk: A population study of 3.3 million people, Schramm TK, et al Circulation 2008; DOI: 10.1161/circulationaha.107.720847.
  19. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore, Julia Hippisley-Cox, University of Nottingham, BMJ 2009;338:b880. 
  20. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2, BMJ 2008;336:a332,  doi:10.1136/bmj.39609.449676.25.
(Note: We are not responsible for the content of these external documents and websites).

page updated 06/05/17